NYLI Balanced Class C MBACX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 32.70  /  +0.09 %
  • Total Assets 447.7M
  • Adj. Expense Ratio
    2.080%
  • Expense Ratio 2.070%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity Medium/Limited
  • Status Open
  • TTM Yield 0.92%
  • Turnover 201%

USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:11 AM GMT+0

Morningstar’s Analysis MBACX

Will MBACX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

NYLI Balanced Class C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MBACX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 28.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United States Treasury Notes 3.75%

4.41 20M
Government

iShares Intermediate Govt/Crdt Bd ETF

3.79 17M

Vanguard Intmdt-Term Trs ETF

3.64 16M

Alphabet Inc Class C

3.31 15M
Communication Services

United States Treasury Notes 4.125%

3.20 14M
Government

United States Treasury Notes 3.875%

2.36 11M
Government

United States Treasury Notes 3.875%

2.20 10M
Government

JPMorgan Chase & Co

2.15 10M
Financial Services

Merck & Co Inc

1.60 7M
Healthcare

Johnson & Johnson

1.58 7M
Healthcare

Sponsor Center